Sleep duration

Sleep duration has been studied in 672 papers since 2015: 2 trials and 629 observational studies in people, 1 in animals, 38 reviews; 255 in the past year. The newest paper, Nov 20, 2026: “Sleep characteristics, glymphatic proxies, and ATN biomarkers in Alzheimer’s disease”.

Intervention

672 papers study it562 findingsUpdated

MeSH

Research on it is growing 25% faster than aging research as a whole: 56 papers in the latest year counted

57 new papers in 30 daysSee all 671 papers on sleep duration

At a glance

Sleep duration is linked with mortality, cognitive function and frailty in human observational studies, with independent labs reporting these links again. Some studies find no clear mortality link; short and long sleep are also linked with biological-age acceleration. Some authors are company-affiliated, and some papers declare company ties.

562 findings in 429 papers from 2015 to 2026, 103 of them since April 2026

Independent labs found the same change in people. 244 independent labs in 38 countries.

“Performance peaked at 7 h of sleep duration for all three games in the sample as a whole”
Sleep and Cognitive Performance From Teens To Old Age: More Is Not BetterSleep2017doi:10.1093/sleep/zsw029

86 of its findings point the other way.

Humans: replicated by independent labs. Worms or flies: a single group. Cells and mice: nothing yet.
  • 244 independent labs in 38 countries
  • 86 findings against
  • Funders: National Institute on Aging and others
  • 32 of 547 findings with company ties
  • Human trial2
  • Humans628
  • Model organisms1
  • In silico2

What did studies of sleep duration find?

95

Studies of sleep duration measured 95 outcomes; the most studied are cognitive function (14 studies), sarcopenia (4) and telomere length (3).

Cognitive function

downin humans7no changein humans3upin humans2mediatesin humans1+1

14 studies
  1. Sleep duration is linked with better cognitive function in AD with WMH+.

    Humansin AD with WMH+n = 735

  2. Sleep duration is linked with lower cognitive function in humans (β -0.05 to -0.03 per SD increase).

    Humansn = 27,343

  3. Sleep duration is linked with better cognitive function in humans.

    Humans2-weekn = 35

  4. Sleep duration is linked with worse cognitive function in humans (vs. < 9 hours).

    Humansvs. < 9 hours14 years

  5. Sleep duration is linked with worse cognitive function in humans.

    Humansn = 422,106

  6. Sleep duration is linked with worse cognitive function in humans (compared to those with 6 h sleep) (adjusted β -0.36, 95% CI -0.71 to -0.02).

    Humanscompared to those with 6 h sleep≤5 h per day

  7. Sleep duration is linked with cognitive function in humans (association between ADLs and cognitive, depression and dual trajectories) (3.14%, 6.14%, and 2.70% (P < 0.05)).

    Humansassociation between ADLs and cognitive, depression and dual trajectories

  8. Sleep duration was not clearly linked with cognitive function in humans (participants using antidepressants without depressive symptoms).

    Humansparticipants using antidepressants without depressive symptoms

  9. Sleep duration was not clearly linked with cognitive function in humans (without chronic kidney disease).

    Humanswithout chronic kidney diseasen = 3,215

  10. Sleep duration is linked with worse cognitive function in dementia-free participants.

    Humansin dementia-free participants

All 14

Sarcopenia

no changein humans3mediatesin humans1OR 1.081–2.093

4 studies
  1. Sleep duration is linked with sarcopenia in humans (between depression and sarcopenia) (11.8% of total association).

    Humansbetween depression and sarcopenian = 4,067

  2. Sleep duration was not clearly linked with sarcopenia in humans (OR 1.081, 95% CI 0.807 to 1.449).

    Humans5-yearn = 2,521

  3. Sleep duration was not clearly linked with sarcopenia in humans (adjusted OR 2.093, 95% CI 0.753-5.812, p=0.157).

    Humans2-yearfemalesn = 1,353

  4. Sleep duration was not clearly linked with sarcopenia in humans.

    Humans

More on Sarcopenia

Telomere length

no changein humans2upin humans1

3 studies
  1. Sleep duration is linked with higher telomere length in humans (Mendelian randomization; linear relationship).

    HumansMendelian randomization; linear relationshipgenetically predictedleukocyten = 442,664

  2. Sleep duration was not clearly linked with telomere length in humans.

    Humans

  3. Sleep duration was not clearly linked with telomere length in humans (adjusted for sociodemographic and health indicators).

    Humansadjusted for sociodemographic and health indicatorsn = 2,936

More on Telomere length

Mortality

no changein humans3

3 studies
  1. Sleep duration was not clearly linked with mortality in humans (Mendelian randomization).

    HumansMendelian randomizationn = 451,420

  2. Sleep duration was not clearly linked with mortality in humans among those with existing chronic diseases.

    Humansamong those with existing chronic diseases

  3. Sleep duration was not clearly linked with mortality in humans.

    Humans< 7 h/night versus 7-8 h/night

Grip strength

downin humans1downin silico1

2 studies
  1. Sleep duration is linked with worse grip strength in humans (-0.14 kg per year; 95% CI: -0.26 to -0.03).

    Humans≥9 height-year follow-up periodfemalesn = 6,429

  2. Sleep duration impairs grip strength in silico.

    In silico

Depressive symptoms

downin humans1no changein humans1

2 studies
  1. Sleep duration is linked with lower depressive symptoms in humans (cross-sectional analysis) (B = -0.548, 95% CI (-0.628, -0.468)).

    Humanscross-sectional analysisn = 5,111

  2. Sleep duration was not clearly linked with depressive symptoms in humans (P>0.05).

    Humansmales

More on Depressive symptoms

Lifespan

upin flies1downin Mammalia1

2 studies
  1. Sleep duration shortens lifespan in Mammalia.

    Review

  2. Sleep duration extends lifespan in flies (short-sleep versus long-sleep Sleep Inbred Panel lines) (∼16% longer life span).

    Model organismsshort-sleep versus long-sleep Sleep Inbred Panel lines

Frailty

no changein humans1downin silico1

2 studies
  1. Sleep duration was not clearly linked with frailty in humans.

    Humansn = 1,643

  2. Sleep duration decreases frailty in silico (β = - 0.36, 95% CI - 0.49 to - 0.22).

    In silico

Type 2 diabetes

no changein humans2

2 studies
  1. Sleep duration was not clearly linked with type 2 diabetes in humans.

    Humansn = 23,023

  2. Sleep duration was not clearly linked with type 2 diabetes in subjects with good sleep quality.

    Humansin subjects with good sleep quality

More on Type 2 diabetes

Executive function

downin humans2

2 studies
  1. Sleep duration is linked with worse executive function in humans (controlled for age, sex, race/ethnicity, education, and cognitive status) (β=-0.249, 95% CI -0.355 to -0.143).

    Humanscontrolled for age, sex, race/ethnicity, education, and cognitive status>8 hours

  2. Sleep duration is linked with worse executive function in humans (p = .015).

    Humansfemales

All 95

What is sleep duration linked with?

268

Studies link sleep duration with 268 measures, most often mortality (22 studies), cognitive function (20) and cognitive impairment (13).

Mortality

upin humans17mixedin humans3downin humans2HR 0.78–11.15

22 studies
  1. Sleep duration is associated with mortality in humans (heart disease) (HR 1.51, 95% CI 1.32–1.73).

    Humansheart disease≥9 hours versus 7–8 hours15 yearsn = 3,287

  2. Sleep duration is associated with mortality in humans (Advanced (Stage 3–4) cardiovascular-kidney-metabolic syndrome) (HR 1.21, 95% CI 1.00–1.46; P = .05).

    HumansAdvanced (Stage 3–4) cardiovascular-kidney-metabolic syndrome>8 hours per night versus 7–8 hoursMedian 7.6 years of follow-upn = 4,266

  3. Sleep duration is associated with mortality in humans (Unfavorable-to-favorable sleep duration versus consistently unfavorable sleep duration) (HR 0.78, 95% CI 0.61–0.99).

    HumansUnfavorable-to-favorable sleep duration versus consistently unfavorable sleep durationMedian 9.01 yearsn = 6,374

  4. Sleep duration is linked with a higher risk of mortality in humans (adjusted HR 1.17 (95% CI 1.01-1.35)).

    Humans30.8 yearsn = 3,305

  5. Sleep duration is associated with mortality in humans (fully adjusted model) (HR 1.17 (1.01-1.35), P=0.035).

    Humansfully adjusted modeln = 435

  6. Sleep duration is associated with mortality in humans.

    Humansup to 15 yearsn = 29,997

  7. Sleep duration is linked with a higher risk of mortality in humans (adjusted HR 11.15, 95% CI 6.54–19.01).

    Humanshighest Charlson Comorbidity Index category, compared with 7-8 hours sleep and no multimorbidityup to 15 yearsn = 29,997

  8. Sleep duration is associated with mortality in humans (Patients with inflammatory bowel disease) (21% lower risk; HR 0.79, 95% CI 0.66–0.95).

    HumansPatients with inflammatory bowel disease7-8 hours per dayMedian 14.6-year follow-upn = 4,262

  9. Sleep duration is associated with mortality in humans (short (<6 hours) and long (>8 hours) sleep compared to normal ([6-8] hours)).

    Humansshort (<6 hours) and long (>8 hours) sleep compared to normal ([6-8] hours)

  10. Sleep duration is linked with a higher risk of mortality in humans (long sleep duration (>8 vs 7-8 hours)) (HR 1.27; 95% CI 1.06 to 1.53).

    Humanslong sleep duration (>8 vs 7-8 hours)7.36 yearsn = 2,468

All 23

Cognitive function

downin humans7mixedin humans7upin humans6

20 studies
  1. Sleep duration is associated with cognitive function in humans (Longer sleep in Alzheimer's disease with WMH+; exploratory finding).

    HumansLonger sleep in Alzheimer's disease with WMH+; exploratory finding

    Sleep's link to brain damage varies with other vessel injuries

    Alzheimer's & dementia : the journal of the Alzheimer's Association
  2. Sleep duration is associated with cognitive function in humans (short (5-6 hours) and long (9-10 hours) sleep duration) (all p < 0.001).

    Humansshort (5-6 hours) and long (9-10 hours) sleep durationbrainn = 38,816

  3. Sleep duration is associated with cognitive function in humans.

    Humansn = 326

  4. Sleep duration is associated with cognitive function in humans.

    Humans

  5. Sleep duration predicts cognitive function in humans.

    Humans

  6. Sleep duration is associated with cognitive function in humans.

    Humans

  7. Sleep duration is associated with cognitive function in humans (optimal sleep duration 5.8-7 h in CHARLS and 6-6.7 h in SHARE).

    Humansoptimal sleep duration 5.8-7 h in CHARLS and 6-6.7 h in SHARE

  8. Sleep duration is associated with cognitive function in humans.

    Humans

  9. Sleep duration is associated with cognitive function in humans (overweight and obese (BMI ≥ 25 kg/m2)).

    Humansoverweight and obese (BMI ≥ 25 kg/m2)n = 2,243

  10. Sleep duration is associated with cognitive function in humans (cross-sectional analysis) (inflection point at SD = 6 h).

    Humanscross-sectional analysis

All 21

Cognitive impairment

upin humans11downin humans1mixedin humans1OR 1.28–1.96

13 studies
  1. Sleep duration is linked with a higher risk of cognitive impairment in type 2 diabetic patients aged 60 and above with total daily sleep <6 hours (OR = 1.96, 95% CI: 1.25-3.09).

    Humansin type 2 diabetic patients aged 60 and above with total daily sleep <6 hours<6 hoursn = 1,044

  2. Sleep duration is associated with cognitive impairment in humans (Multivariate analysis in community-dwelling older adults).

    HumansMultivariate analysis in community-dwelling older adults> 8 hn = 2,830

  3. Sleep duration is linked with a higher risk of cognitive impairment in humans (HR 1.13, 95% CI 1.00-1.28).

    Humans7.4 yearsmalesn = 2,670

  4. Sleep duration is linked with a higher risk of cognitive impairment in humans (short sleep duration vs normal sleep duration).

    Humansshort sleep duration vs normal sleep duration10-year follow-upn = 4,988

  5. Sleep duration is associated with cognitive impairment in humans.

    Humans7–8 hoursn = 186,562

  6. Sleep duration is linked with a higher risk of cognitive impairment in humans (>8 hours/day) (RR = 2.167, 95% CI 1.327∼3.539).

    Humans>8 hours/day

  7. Sleep duration is associated with cognitive impairment in humans (unadjusted, compared with 6 h sleep per day) (OR 1.70, 95% CI 1.05-2.74 (insignificant after adjustment)).

    Humansunadjusted, compared with 6 h sleep per day≤5 h per day

  8. Sleep duration is linked with a higher risk of cognitive impairment in humans (OR 1.280, 95% CI 1.053-1.557).

    Humans

  9. Sleep duration is linked with a higher risk of cognitive impairment in humans (long sleep duration (> 8 h) vs moderate sleep (7-8 h)) (OR 1.41, 95% CI 1.05-1.87).

    Humanslong sleep duration (> 8 h) vs moderate sleep (7-8 h)6.9 ± 2.1 yearsn = 623

  10. Sleep duration is linked with a higher risk of cognitive impairment in humans (normal cognition at baseline).

    Humansnormal cognition at baseline

All 14

More on Cognitive impairment

Frailty

upin humans8downin humans4OR 1.66–1.99

11 studies
  1. Sleep duration is linked with a lower risk of frailty in humans.

    Humansnormal or long versus short sleep; transition into medium- and high-level increase trajectoriesnormal 6-8 h/day; long >8 h/day

  2. Sleep duration predicts frailty in humans (β = - 0.34, P < 0.001).

    Humans

  3. Sleep duration is linked with a higher risk of frailty in humans (compared with normal sleep duration (6-8 h)) (OR = 1.99, 95% CI 1.64-2.41, P < 0.001).

    Humanscompared with normal sleep duration (6-8 h)≤ 5 h

  4. Sleep duration is associated with frailty in humans (<5 hours or >8 hours).

    Humansn = 2,647

  5. Sleep duration is associated with frailty in humans (r=-0.1741, p=0.0258).

    Humansn = 124

  6. Sleep duration is associated with frailty in humans (compared to 7-8 h of sleep) (AOR: 0.68; CI: 0.51-0.91).

    Humanscompared to 7-8 h of sleep≥ 9 h

  7. Sleep duration is associated with frailty in humans (compared to optimal-stable group) (OR 1.66, 95% CI 1.13-2.46).

    Humanscompared to optimal-stable group

  8. Sleep duration is associated with frailty in humans (< 6 h sleep duration) (16% (95% CI 6%, 28%) higher FI).

    Humans< 6 h sleep durationmales

  9. Sleep duration is associated with frailty in humans.

    Humans

  10. Sleep duration is linked with a higher risk of frailty in humans (HR 1.13, 95% CI 1.04-1.22).

    Humans>8.5 hours

All 12

Dementia

upin humans7downin humans1+64% riskHR 0.93–2.57

8 studies
  1. Sleep duration is associated with dementia in humans (HR 0.93; 95% CI 0.86–1.00; p = 0.04).

    HumansModels adjusted for sociodemographic and lifestyle behavioral factors; association attenuated in within-pair analyses13.42 yearsn = 13,087

    Genetic tendency to nap linked to dementia in Swedish twins

    Alzheimer's & dementia : the journal of the Alzheimer's Association
  2. Sleep duration is linked with a higher risk of dementia in humans (cross-sectional) (OR 2.99, 95% CI: 2.47-3.62).

    Humanscross-sectional<5 h or >10 hn = 12,187

  3. Sleep duration is linked with a higher risk of dementia in humans (mild cognitive impairment) (HR 2.57, 95% CI 1.62-4.02).

    Humansmild cognitive impairment

  4. Sleep duration is linked with a higher risk of dementia in humans (compared to ideal sleep duration (7-8 h)) (+64% risk).

    Humanscompared to ideal sleep duration (7-8 h)8 (± 2.9) yearsn = 7,223

  5. Sleep duration is linked with a higher risk of dementia in humans (relative to 7 hours) (adjusted HR 1.46, 95% CI 1.00-2.15).

    Humansrelative to 7 hours8.0 yearsn = 13,601

  6. Sleep duration is linked with a higher risk of dementia in humans (vs. 7-8 h) (HR 1.69 (95% CI 1.01-2.83)).

    Humansvs. 7-8 hmean follow-up of 3.7 yearsn = 1,982

  7. Sleep duration raises the risk of dementia in humans (compared with 7-8 hours) (short: RR = 1.18, 95% CI = 1.09 to 1.28; long: RR = 1.28, 95% CI = 1.15 to 1.43).

    Reviewcompared with 7-8 hours<7 hours or >8 hours

  8. Sleep duration is associated with dementia in older adults with MCI or AD.

    Reviewin older adults with MCI or AD

More on Dementia

Sarcopenia

upin humans5mixedin humans1downin humans1OR 1.41–2.41

7 studies
  1. Sleep duration is associated with sarcopenia in humans (patients receiving peritoneal dialysis) (U-shaped association; lowest estimated odds at approximately 7.29 h/night).

    Humanspatients receiving peritoneal dialysisn = 562

  2. Sleep duration is associated with sarcopenia in humans.

    Humans

  3. Sleep duration is linked with a higher risk of sarcopenia in humans (abnormal sleep duration).

    Humansabnormal sleep duration

  4. Sleep duration is linked with a higher risk of sarcopenia in humans (long sleep (≥8 h)) (OR 1.41 (95% CI 1.01-2.02), p < 0.05).

    Humanslong sleep (≥8 h)

  5. Sleep duration is linked with a higher risk of sarcopenia in humans (OR 2.41, 95% CI 1.13-5.17).

    Humans2-yearmalesn = 1,353

  6. Sleep duration is associated with sarcopenia in humans (P < .001).

    Humans

  7. Sleep duration raises the risk of sarcopenia in humans (individuals with metabolic syndrome).

    Reviewindividuals with metabolic syndrome>9 hours

More on Sarcopenia

Telomere length

downin humans3upin humans3mixedin humans1

7 studies
  1. Sleep duration is associated with telomere length in humans (breast cancer survivors).

    Humansbreast cancer survivorsexcessivefemalesn = 262

  2. Sleep duration is associated with telomere length in humans (Observational analysis; association shape differed between linear and spline models).

    HumansObservational analysis; association shape differed between linear and spline modelsself-reportedleukocyten = 442,664

  3. Sleep duration is associated with telomere length in type 2 diabetes mellitus patients (β=-0.123, 95% CI: -0.229 to -0.017, p=0.022).

    Humansin type 2 diabetes mellitus patientsn = 1,027

  4. Sleep duration is associated with telomere length in humans (P = 0.001).

    Humansn = 310,091

  5. Sleep duration is associated with telomere length in humans.

    Humans

  6. Sleep duration is associated with telomere length in humans (postmenopausal women) (27-base-pair per additional hour (95% CI: 6, 48)).

    Humanspostmenopausal womeneach additional daily hour of sleep beyond 5 hoursfemalesn = 3,145

  7. Sleep duration is associated with telomere length in humans (β=0.086, P<0.01).

    Humansafter controlling for the effects of gender, age, marital status, income level, residence, smoking, drinking, physical exercise and disease statusleukocyten = 176

More on Telomere length

Multimorbidity

upin humans4mixedin humans2downin humans1OR 1.63–1.64

7 studies
  1. Sleep duration is associated with multimorbidity in humans (Compared with 6–8 h sleep) (aOR 1.65, 95% CI 1.22–2.25).

    HumansCompared with 6–8 h sleep≥9 hn = 2,998

  2. Sleep duration is associated with multimorbidity in humans (Short sleep; fully adjusted model) (OR 1.640, 95% CI 1.505–1.788).

    HumansShort sleep; fully adjusted modeln = 18,664

  3. Sleep duration is linked with a higher risk of multimorbidity in humans (Deteriorated sleep duration) (OR = 1.63, 95% CI: 1.09-2.39).

    HumansDeteriorated sleep durationn = 1,822

  4. Sleep duration is linked with a lower risk of multimorbidity in humans (hypertension) (aOR 0.768, 95% CI 0.710-0.831).

    Humanshypertensionn = 16,953

  5. Sleep duration is associated with multimorbidity in humans (Prolonged sleep in females: HR 1.68, 95% CI 1.17–2.40).

    Humansinsufficient and prolonged sleep5 yearsn = 138,126

  6. Sleep duration is associated with multimorbidity in humans.

    Humans

  7. Sleep duration is associated with multimorbidity in humans.

    Humansn = 19,752

More on Multimorbidity

Hypertension

upin humans3mixedin humans2downin humans1OR 0.78–1.33

6 studies
  1. Sleep duration is associated with hypertension in humans (U.S. adults) (Prevalence 40.1% vs 30.3%; PR 1.32).

    HumansU.S. adults≤5 hrs versus 7-9 hrsn = 366,571

  2. Sleep duration is associated with hypertension in humans (older adults in Padang Timur Village).

    Humansolder adults in Padang Timur Villagen = 62

  3. Sleep duration is linked with a lower risk of hypertension in humans (OR 0.78, 95% CI 0.64-0.94).

    Humans6-7 hn = 5,872

  4. Sleep duration is associated with hypertension in humans (naturally postmenopausal women; insufficient and excessive sleep) (U-shaped association).

    Humansnaturally postmenopausal women; insufficient and excessive sleepfemalesn = 3,560

  5. Sleep duration is linked with a higher risk of hypertension in humans (OR 1.27 (95%CI 1.04-1.56)).

    Humansadjusted for gender, age, education, economic factors, sitting time, smoking, drinking, obesity<7 h/dn = 4,078

  6. Sleep duration is associated with hypertension in humans (Adjusted for potential confounding variables) (OR 1.33, 95% CI 1.00–1.77).

    HumansAdjusted for potential confounding variables≥9 h per 24-h period versus six to eight hoursmalesn = 967

More on Hypertension

Depressive symptoms

downin humans3upin humans2mixedin humans1

6 studies
  1. Sleep duration is associated with depressive symptoms in humans (Chinese adults; directional lagged association) (β = -0.064, 95% CI: -0.110, -0.018).

    HumansChinese adults; directional lagged associationn = 12,747

  2. Sleep duration is associated with depressive symptoms in humans (~ 6.5 h).

    Humansn = 10,706

  3. Sleep duration predicts depressive symptoms in humans.

    Humans

  4. Sleep duration is associated with depressive symptoms in humans (B = -0.443, P < 0.001).

    Humansn = 6,527

  5. Sleep duration is associated with depressive symptoms in humans.

    Humans

  6. Sleep duration is associated with depressive symptoms in humans (Interaction with activities of daily living in the regression on depressive symptoms) (8.31–10.19 h sleep duration: range within which the detrimental association of frailty with depressive symptoms was offset).

    HumansInteraction with activities of daily living in the regression on depressive symptomsn = 1,429

More on Depressive symptoms

All 268

Funding

11 grants since 2018

National Heart, Lung, and Blood Institute$1.9MNational Institute on Aging$2.8MJapan Society for the Promotion of Science¥8.8M

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human observational studies link short or long sleep with mortality and biological-age acceleration; independent labs reproduce links between sleep duration and mortality, cognition and frailty. Some analyses show no clear mortality link. Some papers declare company ties or include company-employed authors.

  2. Summary rewritten as its findings changed.

    As it read before

    Short and long sleep are linked with higher mortality and biological-age acceleration in human observational studies, with aging measures lowest around seven hours. Independent labs report links with mortality, cognition, and frailty, although some studies find no clear mortality link. Some authors work at companies, and some papers declare company ties.

  3. Summary rewritten as its findings changed.

    As it read before

    Human observational studies link short or long sleep with mortality, biological-age acceleration and cognitive impairment; independent labs reproduce cognition and frailty associations. Telomere associations differ across studies and models, and 46 findings oppose the predominant direction for their outcome. Some authors work at companies, and seven papers declare company ties.

  4. Summary rewritten as its findings changed.

    As it read before

    A human study and a review link sleep duration to mortality; another human study associates it with memory in women. The mortality study finds no association with cardiovascular mortality, while the review reports no effect on cancer incidence. Human results comprise three findings from two independent labs, without same-outcome replication.

  5. Summary written from the findings.

Latest

Dec 2025: 34Jan 2026: 25Feb 2026: 19Mar 2026: 23Apr 2026: 14May 2026: 10Jun 2026: 21Jul 2026: 19Aug 2026: 3Sep 2026: 12Oct 2026: 35Nov 2026: 33248 papers in 12 months

See all 671 papers on sleep duration